kat

A while ago, I spent most of my time learning about CRISPR and protein engineering.

I was scientifically raised by the founding team of Scribe Therapeutics, where I worked on Self Inactivating AAVs, among other projects.

Then I became an independent researcher. I learned a lot of things the hard way, as I explored metabolic engineering at an Invisible College.

I am helping discover the enzymatic pathway for Mescaline and 5-MeO DMT with the Alexander Shulgin Research Institute.

I want to be imagining and creating general tools for engineering biology full time.

February 2022